Evan Loh, CEO at Paratek Pharmaceuticals, Inc. (PRTK), sold 9,595 shares at $4.75 ($46K) on 2020-05-12, disclosed to the SEC on 2020-05-14.
Open-market sale of $46k PRTK by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PRTK | SELL | 2022-12-14 | $393K | — | Filing → |
| PRTK | SELL | 2022-11-01 | $31K | — | Filing → |
| PRTK | SELL | 2022-08-10 | $237K | — | Filing → |